Modalis Therapeutics Corp 4883.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 11:01 AM JST
2,213.00quote price arrow down-8.00 (-0.36%)
Volume
67,000
52 week range
1,701.00 - 4,070.00

...

Loading . . .

KEY STATS

  • Open2,202.00
  • Day High2,248.00
  • Day Low2,175.00
  • Prev Close2,221.00
  • 52 Week High4,070.00
  • 52 Week High Date08/25/20
  • 52 Week Low1,701.00
  • 52 Week Low Date12/17/20
  • Market Cap595.33M
  • Shares Out28.52M
  • 10 Day Average Volume281,400
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)15.10
  • P/E (TTM)146.56
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Modalis Therapeutics Corp News

There is no recent news for this security.

Latest 4883.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Modalis Therapeutics Corp is a Japan-based company engaged in the research and development of gene therapy drugs using the core platform CRISPR-GNDM technology. The Company develops gene therapy drugs that use CRISPR-GNDM technology, which is a unique platform technology, for genetic diseases caused by errors in the genetic code and epigenetics. The Company has two business models. Collaborative model pipeline opens CRISPR-GNDM technology to partners, and develops therapeutic...
Haru Morita
President
Naoki Kobayashi
Chief Financial Officer
Address
4F
Y's Bldg., 16-5, Nihonbashi Kabuto-cho
Chuo-ku, TKY
103-0023
Japan